MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jad.2025.119403

Медицинская библиотека · Journal of affective disorders · 2025

Examining the burden of major depressive disorder with moderate-to-severe insomnia symptoms in five European countries.

Riise Jesper Gottorp, Cambron-Mellott M Janelle, Zhang Zhiheng, Huber Véronique, Pfau Alanna, Yue Leiyu, Dwibedi Nilanjana, Olopoenia Abisola, Geoffroy Pierre A

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Insomnia is a core and prevalent symptom of major depressive disorder (MDD). However, the impact of insomnia on health-related outcomes among patients with MDD remains inadequately understood. This study evaluated the clinical, humanistic, and economic burden of adults with MDD with moderate-to-severe insomnia symptoms (MDDIS) compared to adults with MDD and no-or-mild insomnia symptoms (other-MDD) and adults in the general population without MDD (non-MDD).

METHODS

Data from the European (France, Germany, UK, Italy, Spain) 2020 National Health and Wellness Survey were utilized to identify participants who self-reported a diagnosis of depression, stratified by insomnia status (MDDIS: Insomnia Severity Index [ISI] score ≥ 15; other-MDD: insomnia not experienced in past 12 months or ISI score < 15), and those who did not (i.e. non-MDD). Matched bivariate analyses compared MDDIS with other-MDD and non-MDD.

RESULTS

The study included 1888 MDDIS, 3905 other-MDD, and 52,074 non-MDD participants. In adjusted analyses, MDDIS participants reported greater severity of depressive and anxiety symptoms, daytime sleepiness, more healthcare provider, psychiatrist and emergency room visits, hospitalizations, and 6-month per-person direct medical costs compared to other-MDD and non-MDD (all P < 0.01) and greater medication non-adherence compared to other-MDD (P < 0.001). MDDIS participants reported poorer mental and physical functioning, poorer health-related quality of life, higher work and activity impairment, and higher annualized per-person indirect costs compared to other-MDD and non-MDD (all P < 0.001).

LIMITATIONS: The cross-sectional nature of the study limits causal inferences.

CONCLUSIONS

This study highlights the severe global burden of MDDIS and the importance of addressing insomnia symptoms with targeted interventions in the treatment of MDD.

Для цитирования: Riise Jesper Gottorp, Cambron-Mellott M Janelle, Zhang Zhiheng, Huber Véronique, Pfau Alanna, Yue Leiyu, Dwibedi Nilanjana, Olopoenia Abisola, Geoffroy Pierre A. Examining the burden of major depressive disorder with moderate-to-severe insomnia symptoms in five European countries.. Journal of affective disorders. 2025. DOI: 10.1016/j.jad.2025.119403.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.